title: Pathogenesis of human cytomegalovirus infection and cellular targets.
abstract: In acquired immunodeficiency syndrome patients with human cytomegalovirus (HCMV), disseminated infection, and end-organ disease, autopsy findings show a generalized HCMV infection of endothelial cells. On the other hand, immunocompromised transplanted patients show presence of virus and virus products in peripheral blood leukocytes (PBL), when affected by a disseminated HCMV infection. All diagnostic assays are based on the detection of virus and viral components in PBL or whole blood, including polymorphonuclear leukocytes and monocytes. The interplay between endothelial cells and leukocytes represents the pathogenetic basis for all clinical syndromes originating during disseminated HCMV infections and is the trigger for the transmission of HCMV from mother to fetus during primary infections of pregnant women. The two biologic properties of endothelial cell tropism and leukocyte (polymorphonuclear- and monocyte-) tropism are shared by all recent clinical HCMV isolates, whereas they are missing in laboratory-adapted strains. The potential role of HCMV in the pathogenesis of atherosclerosis both in the immunocompetent (after angioplasty) and the heart transplant patient is receiving support from seroepidemiologic findings, in vivo animal models, in vitro data, and also some clinical observations. The interaction of endothelial cells and leukocytes with subsequent spreading of infection to smooth muscle cells may be a major pathogenetic mechanism at the basis of this important vascular disease.
authors.affiliation: Servizio di Virologia, IRCCS Policlinico San Matteo, Pavia, Italy. g.gerna@smatteo.pv.it
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Gerna
authors.forename: Fausto
authors.initials: F
authors.lastname: Baldanti
authors.forename: M Grazia
authors.initials: MG
authors.lastname: Revello
mesh_terms: D000956:Antigens, Viral / Q000378:metabolism; D003581:Cytodiagnosis / Q000379:methods; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000150:complications / Q000175:diagnosis / Q000209:etiology*; D004279:DNA, Viral / Q000378:metabolism; D042783:Endothelial Cells / Q000473:pathology / Q000821:virology*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D016867:Immunocompromised Host; D007963:Leukocytes, Mononuclear / Q000473:pathology / Q000821:virology*; D009000:Monocytes / Q000473:pathology / Q000821:virology; D009504:Neutrophils / Q000737:chemistry / Q000473:pathology / Q000821:virology; D010750:Phosphoproteins / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism; D014763:Viral Matrix Proteins / Q000378:metabolism; D014766:Viremia / Q000175:diagnosis
chemical_list: D000956:Antigens, Viral; D004279:DNA, Viral; D010750:Phosphoproteins; D012367:RNA, Viral; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa